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Abstract
Objective—Chronic disease affects both patients and spouses, yet the effect of vasculitis on the
spouses of patients has not been systematically examined. We addressed this research gap by
describing 8 dimensions of health-related quality of life (HRQOL) for antineutrophil cytoplasmic
antibody–associated vasculitis (AAV) patients and their spouses and compared patients and spouses
with norms for the general US population. We also determined whether the impact of AAV on
HRQOL differs by sex for patients or their spouses.
Methods—Ninety-seven patients with AAV and their spouses completed a mailed questionnaire
that included demographic information and a measure of HRQOL (Medical Outcomes Study Short
Form 36.) Using the RAND method, we calculated 8 HRQOL dimensions: general health, physical
functioning, emotional role limitations, physical role limitations, social functioning, mental health,
bodily pain, and energy/vitality. Using norm-based scores, we compared the HRQOL of patients and
spouses with the general US population. We then used multivariate analysis of covariance
(MANCOVA) test for sex differences in HRQOL for patients and spouses.
Results—Patients with AAV scored lower than the US norm on all HRQOL subscales with the
exception of bodily pain. In contrast, spouses scored similarly to national norms. When age,
education, race, illness duration, and disease severity were controlled, there were no significant sex
differences in HRQOL for patients or spouses.
Conclusion—AAV negatively impacts HRQOL for patients; whereas, spouses do not appear to be
as negatively impacted. Long-term marriages may attenuate the effect of sex on HRQOL. Quality
of life should be assessed throughout the disease course for both patients and spouses.
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The vasculitides are a family of rare autoimmune diseases that cause inflammation of blood
vessels. Three types of vasculitis, Wegener’s granulomatosis (WG), Churg-Strauss syndrome
(CSS), and microscopic polyangiitis (MPA) primarily attack small blood vessels and are
associated with antineutrophil cytoplasmic antibodies (ANCAs) (1). Together, these types of
vasculitis are known as ANCA-associated vasculitis (AAV). During the past 40 years, the
advent of more effective drug regimens has transformed vasculitis from a frequently fatal, acute
disease to a chronic condition with relapsing and remitting episodes and chronic sequelae that
most patients live with for many years.
As with other chronic conditions, there is considerable evidence that vasculitis negatively
impacts the health-related quality of life (HRQOL) of patients (2–9). However, to our
knowledge no studies have investigated whether vasculitis differentially impacts quality of life
in men and women, even though female patients with other rheumatic illnesses often fare worse
than male patients on various dimensions of quality of life, including pain, psychological
distress, and activity limitations (10). Furthermore, prior research suggests that vasculitis may
affect men and women differently. For example, Reinhold-Keller and colleagues (4) found that
among vasculitis patients age <40 years, women had a 2.6 times higher risk than men of
becoming unemployed after receiving a diagnosis of WG. Identifying whether AAV impacts
quality of life differently for men and women, and what those differences are, is important in
order to determine if sex-specific interventions targeting HRQOL are warranted.
Similarly, no published studies have reported how vasculitis affects quality of life for spouses
of vasculitis patients. This gap in the literature exists despite increasing recognition that chronic
illness is a stressor for both patients and their spouses (11,12) and the management of chronic
illness is a dyadic process that involves spouses (13). Furthermore, research suggests that other
chronic rheumatic illnesses negatively influence spouses’ quality of life. For example, das
Chagas Medeiros et al (14) reported that spouses of rheumatoid arthritis patients experienced
negative impacts on emotional and mental health. Moreover, in studies of married couples
where one person has a chronic illness (e.g., dementia, Parkinson’s disease, or cancer) sex
differences in quality of life exist for spouses. For example, female spouses have consistently
reported more psychiatric morbidity, including distress (15), than male spouses of chronic
disease patients (16). Thus, characterizing spouses’ HRQOL, and determining whether male
and female spouses report similar HRQOL is important and could help inform future
interventions for married couples facing the illness.
We addressed the research gaps described above using data collected from AAV patients and
their spouses as part of the Partners Adjusting to Illness with Relationship Support (PAIRS)
study. Our goals were to describe 8 domains of HRQOL for patients and their spouses and
compare them with general US population norms; and to examine whether sex differences exist
with regard to these 8 domains for patients and their spouses. We also sought to determine
whether patient and spouse HRQOL were significantly correlated.
SUBJECTS AND METHODS
Subjects
All data were derived from the PAIRS study, a longitudinal, observational study of married
couples in which one partner had AAV. In the PAIRS study, patients and their spouses were
assessed at baseline and again 1 year later. At each time point, both the patient and spouse
completed a mailed questionnaire at home and then traveled to the study office to complete a
2-hour tape-recorded interview. The PAIRS study was approved by the Institutional Review
Board of the University of North Carolina.
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Participants for the PAIRS study were recruited through 2 strategies. Recruitment letters were
mailed to known AAV patients who had previously signed Glomerular Disease Collaborative
Network (GDCN) registry consent forms to be contacted for future research (n = 235) or who
were part of the GDCN but had not signed a consent form to be contacted about future studies
(n = 152). In the latter case, patients’ physicians were asked to address and forward a
prestamped study recruitment letter to patients. All GDCN patients had a histopathologic
finding compatible with AAV and/or surrogate markers for WG (1), with verification of a
positive ANCA test determined by immunofluorescence microscopy and antigen-specific
enzyme-linked immunosorbent assay (ELISA) (17). We recruited 79 couples using this first
strategy.
The second recruitment strategy involved posting a variety of recruitment announcements in
vasculitis patient newsletters, websites, and support group meetings. It is unknown how many
AAV patients were exposed to these announcements; however, 111 were recruited using this
method. An additional 7 couples were either recruited in person at the 2006 annual Vasculitis
Foundation Conference or recruited from a previous study led by the principal investigator
(CTT) of the Vasculitis Self-Management study. All patients recruited through the second
strategy had a self-reported diagnosis of AAV.
All interested patients who contacted study staff in response to these recruitment efforts (n =
197) completed a telephone screening to determine eligibility. Couples were excluded (n = 5)
if the patient did not have a self-reported diagnosis of AAV for at least 6 months; the couple
was not currently legally married; either partner was younger than age 18 years; the patient
was currently on dialysis; either partner could not read, speak, and write in English or; either
partner had a significant uncorrected hearing problem. We limited our sample to legally-
married couples in order to control for differences that may exist between married couples and
other types of couples (e.g., cohabitating unmarried couples, same-sex couples). Lastly,
couples who did not agree to travel to a study interview office to complete the interview (n =
42) or who were uninterested in participating after learning more about the study via telephone
(n = 11) were excluded. All couples who were deemed eligible during the telephone screening
(n = 139) were mailed study consent forms (one for each couple member) and a patient Health
Insurance Portability and Accountability Act consent form asking permission to contact the
patient’s primary vasculitis physician about his or her condition.
Of the 139 eligible and interested couples who were mailed consent forms, 113 couples (81%)
provided consent and 97 (70%) returned the completed baseline questionnaires. Reasons for
noncompletion included inability to travel for the first interview session (n = 6), patient too
sick to continue (n = 3), and no desire to continue in the study (n = 7).
Measures
Variables were assessed using the PAIRS study baseline questionnaire, with the exception of
patient disease activity (assessed by physician rating), and data on major medical conditions
(assessed using the followup questionnaire). Scores for multiple-item scales (HRQOL) were
not calculated for individuals if >25% of the scale items were missing; instead, these summary
scores were treated as missing.
We used the RAND 36-item health survey, version 1.0, to assess HRQOL for both patients
and their spouses (18). The 36-items contained in the RAND survey are identical to the Medical
Outcomes Study Short Form 36 (SF-36) (19). The scoring methods for the 2 measures differ,
but produce scores that are almost perfectly correlated with one another (18). The RAND 36-
item health survey assesses 8 domains of HRQOL, including physical functioning (10 items;
α = 0.93), bodily pain (2 items; α = 0.87), role limitations due to physical health (4 items; α =
0.86), role limitations due to emotional health (3 items; α = 0.84), mental health (5 items; α =
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0.83), social functioning (2 items; α = 0.80), energy/vitality (4 items; α = 0.82), and general
health perceptions (5 items; α = 0.79). This measure has demonstrated face validity and
construct validity when used with rheumatoid arthritis and osteoarthritis patients (20);
however, no validity studies have been conducted with AAV patients. For all subscales, higher
scores correspond to higher HRQOL (e.g., higher scores on the bodily pain domain correspond
to less pain).
Parallel sociodemographic information was collected from patients and spouses. These data
included date of birth, age in years, sex, race, and years of education (possible responses 1 to
>17). Race was dichotomized into white versus nonwhite because the number of nonwhite
participants (n = 3) was small. Duration of the current marriage (in years) was assessed by
patient report. Patients also self-reported the presence of a major medical condition (other than
vasculitis) and spouses reported whether they had any major medical conditions.
Marital quality was assessed by one item from the Quality Marriage Index (21), which asks
patients and spouses to rate how happy, everything considered, they are with their marriages.
Responses range from 1 = very unhappy to 10 = perfectly happy.
During the phone screening, patients reported the number of months/years they had been
diagnosed with vasculitis. Values of <1 year (n = 3) were assigned a value of 0.75 years because
this is the halfway point between 6 months (the minimum diagnosis time to be eligible for the
study) and the nearest integer (1 year).
To assess the patient’s level of disease activity, a form was faxed to the patients’ physicians
asking them to rate the patient’s current vasculitis condition (based on their last visit) using a
10-point scale where 1 = remission and 10 = most active disease. Physicians received the form
at approximately the same time patients received their questionnaires.
Statistical analysis
Analyses were conducted using SAS software, version 9.1 (SAS Institute, Cary, NC). In order
to compare the HRQOL of patients and spouses with the general 1998 US population, we
converted the HRQOL subscale scores to norm-based scores using procedures previously
described by Ware and Kosinski (22). Ware and Kosinski’s estimates for the 1998
noninstitutionalized US population were derived from the National Survey of Functional
Health Status and represent 1,982 households that match census data on geographic region,
market size, age, income (socioeconomic status), and household size (22). The mean age for
the 1998 sample was 50.7 years; 59.6% were female, and the majority (84.2%) were white.
Most respondents (79.8%) had at least 12 years of education. Regarding interpretation, a norm-
based score of 50 indicates that the population of interest scored exactly the same as the general
1998 US population (all ages). Similarly, norm-based scores >50 indicate that the population
of interest scored higher than the general 1998 US population (all ages), whereas scores <50
indicate that the population scored lower than the 1998 general US population. For this study,
norm-based HRQOL scores for patients and spouses were presented along with norm-based
scores for the general US population ages 54 – 65 years (i.e., the age group corresponding to
the mean age of our patient and spouse samples) for the sake of age-adjusted comparisons.
Independent sample t-tests were then used to determine whether patients and spouses differed
significantly (α = 0.05) from the general US population (ages 54 – 65 years) on the 8 HRQOL
subscales. We used the norm-based scores in all subsequent analyses.
To investigate sex differences in HRQOL among patients and spouses, we used multivariate
analysis of covariance (MANCOVA) with separate models constructed for patients and
spouses. That is, in the first MANCOVA, the 8 patient HRQOL subscales were the dependent
variables, patient sex was the primary independent variable, and patient age, education, disease
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activity, and years since diagnosis were included as control variables. The second MANCOVA
included the 8 spouse HRQOL subscales as the dependent variables, spouse sex as the primary
independent variable, and spouse age, education, patient disease activity, and years since
diagnosis as control variables. For all MANCOVAs, we first inspected Wilks’ λ. If this statistic
was significant, we then inspected individual analysis of covariance to determine where
differences existed. Last, we calculated Pearson’s correlation to determine whether patient and
spouse HRQOL were related.
RESULTS
Sample characteristic
Demographic and clinical characteristics for couples in the sample are shown in Table 1. The
mean patient and spouse age was ~57 years. Men comprised 55% of the patient sample, and
the majority of patients (97%) and spouses (93%) were white. On average, patients and spouses
had ~15 years of formal education (i.e., some college). Patients had been diagnosed with AAV
for an average of 4.4 years, and couples had been married an average of 30.1 years. Both
patients and spouses reported a substantial degree of happiness in their marriage (mean ± SD
8.3 ± 1.7 and 8.1 ± 1.8, respectively on a 10-point scale.) The overall mean physician-rated
disease activity level was 2.0 on a 10-point scale, and the mean ± SD disease activity level for
male and female patients was 2.1 ± 1.4 and 1.8 ± 1.2, respectively. The majority of patients
(55.3%) did not report a major medical condition other than vasculitis, and most spouses
(69.7%) did not report a major medical condition. Additionally, the average disease duration
(in years) for male and female patients was 4.1 ± 3.8 and 4.9 ± 5.4, respectively.
No significant differences by sex in patient disease activity or disease duration by independent
sample t-tests were seen (t[78] = 0.97, P = 0.33 and t[92] = −0.84, P = 0.40, respectively); and
no difference by chi-square test in the number of male and female spouses reporting a major
medical condition (χ2 = 1.21, P = 0.27).
Normed HRQOL comparisons
Figure 1 presents the SF-36 norm-based HRQOL scores for patients, spouses, and the 1998
general US population ages 55– 64 years. Independent sample t-tests revealed that patients
scored significantly worse than the US population ages 55– 64 years on all HRQOL subscales
with the exception of bodily pain (t[405] = 0.51, P = 0.31). In contrast, spouses scored similarly
to the general US population with the exception of the physical functioning (t[405] = −2.54,
P = 0.006) and bodily pain (t[405] = −2.77, P = 0.003) subscales, on which spouses reported
better physical functioning and less bodily pain.
Comparisons of HRQOL by sex
The unadjusted mean ± SD HRQOL subscale scores for patients and spouses by sex are shown
in Table 2. Additionally, the HRQOL means that have been adjusted for patient or spouse age,
patient or spouse race, patient or spouse education, patient disease duration, and patient disease
severity are shown. MANCOVA analyses revealed that there were no significant differences
in HRQOL between male and female patients (Wilks’ λ 0.72, P = 0.67). Moreover, there were
no significant differences in HRQOL between male and female spouses (λ 1.60; P = 0.15).
Relationship between patient and spouse HRQOL
The correlations between patient and spouse HRQOL are shown in Table 3. Significant
correlations were seen in 7 of 8 HRQOL dimensions (α = 0.05); only physical functioning was
not significant. Patients and spouses were most strongly correlated on social functioning (r =
0.39, P < 0.001) and role limitations due to emotional health (r = 0.27, P < 0.01).
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Similar to previous research findings (2–9), our results indicate that AAV negatively impacts
patient physical and emotional quality of life. Patients with AAV scored significantly lower
than the general 1998 noninstitutionalized US population (ages 55– 64 years) on 7 of the 8
HRQOL dimensions. Particularly negative impacts were seen for general health and role
limitations due to physical health; however, AAV patients were not significantly different from
the general 1998 US population on the dimension of bodily pain. The explanation for this
finding may be that the patients in our sample were healthier than the average patient with
AAV, as evidenced by their willingness to travel to our research offices to complete the
interview portion of our study, and thus, experienced less bodily pain.
In contrast to patients, spouses did not report impaired HRQOL. In fact, spouses reported better
physical functioning and less bodily pain when compared with the general US population.
These findings were surprising given that spouses of chronic disease patients often experience
additional stress from being in a caregiving role, which ultimately impacts spouses’ physical
and emotional health (16,23). A possible explanation for this finding may be that, in our sample,
patients were self-managing their illness well and did not require a great deal of instrumental
assistance from their spouses. Additionally, caregiving may not have taxed spouses’ health as
much as expected because many spouses (70%) did not report having major medical conditions,
which is an indication that spouses may have possessed above-average health. Indeed, a
previous study found that older adults with <4 health conditions were less reactive to stress
than those with >4 health conditions (24). This type of effect may also exist at the couple level,
whereby the HRQOL of both couple members is negatively impacted when the total number
of conditions exceeds 4. Future research should investigate whether there is a dose-response
relationship between total number of health conditions (patient and spouse) and spouse
HRQOL.
It is possible that spouses experienced a negative impact on HRQOL closer to the time of
diagnosis, when both the patient and the spouse were learning to adjust to and cope with AAV.
Previous research has demonstrated that transitioning into a caregiving role leads to an increase
in depressive symptoms for spouses (23). As time passes and patients become more proficient
at managing their illness, they may depend less and less upon their spouse for tangible and
emotional assistance, which could lead to a concomitant improvement in spousal HRQOL over
time. Additionally, spouses may adapt to the caregiving role over time and become more skilled
and confident in providing support to patients, resulting in an improvement in spouses’ HRQOL
over time. Other variables, like marital quality and length of marriage, may influence how well
spouses adapt to the caregiving role and should be explored in future studies.
We did not find significant differences in HRQOL between male and female patients or male
and female spouses. This finding contradicts a substantial body of research that has documented
that women report worse emotional health when compared with men (25,26). Moreover,
research of male and female caregivers has documented that female caregivers are more
distressed by their partner’s illness (12) and, consequently, report more psychiatric
symptomatology than male caregivers (16). One reason why sex differences were not
significant in our study could be that long-term marriages and a high degree of marital quality
buffer the negative impact of chronic disease on female patients’ mental health. As noted
earlier, couples in our study have been married an average of 30 years and reported a high
degree of marital quality. It is possible that sex differences in HRQOL exist for patients who
have not been married as long or who are not happily married. Also, due to our sample size,
we only had the statistical power to detect large significant differences between male and
female patients and spouses (27). Meaningful sex differences in emotional role limitations for
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spouses and emotional well-being for patients and spouses may exist and should be explored
in larger samples.
Additionally, sex differences in quality of life issues not measured by the SF-36 may exist for
our sample. For example, Herlyn et al (2) have shown that female vasculitis patients were more
likely to become unemployed after receiving a vasculitis diagnosis. Because we only measured
HRQOL, we did not capture sex differences that may exist in other aspects of quality of life,
such as employment. The Hoffman Vasculitis questionnaire (3) asks about these additional
quality of life issues and should be considered for future quality of life studies for vasculitis
patients and their spouses.
Our results demonstrate that the HRQOL of patients and spouses are moderately positively
correlated (r = 0.15–0.39). Thus, if patients are experiencing impaired HRQOL, then spouses
may also be experiencing impaired HRQOL. This finding suggests that couples in our study
may have been coping dyadically with vasculitis, which is consistent with previous research
that found that spouses share stressors and engage in coping efforts with patients (11). For this
reason, health practitioners should engage patients and spouses in discussions of how to
optimize disease management. Discussions of managing the illness as a couple may be
particularly important for newly-diagnosed couples and those couples who do not possess a
high degree of marital quality.
The generalizability of our results is limited by the unique characteristics of our sample.
Because most of our couples were older, white, and possessed at least some college education,
they may have been better able to cope with the stressors of chronic illness. Moreover, the
negative impact of vasculitis on the HRQOL of patients and spouses may have been buffered
by positive contextual factors, including a long length of marriage, a high degree of marital
quality, and the health status of spouses. The fact that spouses in our sample reported an absence
of major medical conditions may be particularly limiting because it is possible that spouses
who do not have major medical conditions may be more likely to stay in a relationship with
patients than spouses who have major medical conditions. Although, in the absence of data
representing greater diversity along these dimensions, it is difficult to determine the impact of
these limitations; it is possible that they may have attenuated relationships among our variables.
We grouped 3 types of vasculitis (WG, MPA and CSS) patients together under the umbrella
term of AAV, even though it is unlikely that all of our patients were ANCA positive. In patients
with WG and MPA, approximately 10% are found to be ANCA negative (28), their clinical
symptoms are similar by ANCA status (29), and ANCA are likely pathogenic (30,31). On the
other hand, in CSS there may be differences in symptoms, organ involvement, and prognosis
between patients with and without ANCA positivity; with those who are ANCA positive having
symptoms and pathology more similar to patients with WG and MPA (32). In our previous
studies, CSS patients have accounted for <1% of the sample (33), therefore it is unlikely that
patients with this diagnosis accounted for a large portion of the sample in this study. It is also
possible that grouping different vasculitis patients together masked differences in quality of
life that may be attributable to permanent disease damage, which can differ for WG and MPA
patients. Future studies with larger samples should investigate whether HRQOL differs
between patients with WG, MPA, and CSS. Furthermore, when immunofluorescence
microscopy and antigen-specific ELISA are available, researchers should determine whether
patients who are ANCA positive have poorer quality of life than patients who are ANCA
negative.
Overall, our findings indicate that both male and female patients are negatively impacted across
multiple domains by AAV. This negative impact exists despite the fact that the average patient
disease activity score was 2.0 on a 10-point scale. Thus, health care providers should address
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quality of life issues with patients, with a specific focus on how patients can cope individually
and dyadically with the physical and emotional aspects of the illness. Based on our preliminary
findings, we do not suggest creating sex-specific interventions at this time. Future quality of
life investigations for vasculitis patients and their spouses should incorporate a life-course
perspective to determine how HRQOL changes for patients and spouses over time and whether
changes are related to improved self-management behaviors and social support. Also, future
studies should compare the HRQOL between married and unmarried vasculitis patients to
determine if marital status affects patient HRQOL.
Acknowledgments
Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant P60-AR49465-05) and
the Renal Epidemiology Predoctoral Traineeship at the University of North Carolina Kidney Center.
We would like to thank our coinvestigator, Mary Ann Dooley, the Glomerular Disease Collaborative Network, the
University of North Carolina Kidney Center (specifically Ronald J. Falk, Patrick H. Nachman, Caroline E. Jennette,
Clara Neyhart, RN, and Sheri Kramer), the PAIRS Study staff, the Vasculitis Foundation, and the Churg-Strauss
Syndrome Association for their help with recruitment.
References
1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic
vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187–92.
[PubMed: 8129773]
2. Herlyn K, Reinhold-Keller E, Zeidler A, Raspe H, Gutfleisch J, Peter HH, et al. Health-related quality
of life in primary systemic vasculitides [abstract]. Arthritis Rheum 1998;41 (Suppl 9):S538.
3. Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K. Wegener’s granulomatosis:
patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998;41:2257–
62. [PubMed: 9870883]
4. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Raspe HH, Peter HH, et al. Effect
of Wegener’s granulomatosis on work disability, need for medical care, and quality of life in patients
younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320–5. [PubMed: 12115163]
5. Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients’
perceptions of the effects of systemic lupus erythematosus on health, function, income, and
interpersonal relationships: a comparison with Wegener’s granulomatosis. Arthritis Rheum
2002;47:196–201. [PubMed: 11954014]
6. Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG. Investigation of quality of life, mood,
pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003;49:826–37.
[PubMed: 14673970]
7. Jayne D, Rasmussen N, Andrassy K, Bacon PA, Tervaert JW, Dadoniene J, et al. A randomized trial
of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N
Engl J Med 2003;349:36–44. [PubMed: 12840090]
8. Seo P, Min Y, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, et al. Damage caused by Wegener’s
granulomatosis and its treatment: prospective data from the Wegener’s Granulomatosis Etanercept
Trial. Arthritis Rheum 2005;52:2168–78. [PubMed: 15986348]
9. Thorpe, C. Illness self-management among adults living with ANCA small vessel vasculitis
[dissertation]. Chapel Hill (NC): University of North Carolina; 2006.
10. Theis KA, Helmick CG, Hootman JM. Arthritis burden and impact are greater among US women
than men: intervention opportunities. J Womens Health 2007;16:441–53.
11. Berg CA, Upchurch R. A developmental-contextual model of couples coping with chronic illness
across the adult lifespan. Psychol Bull 2007;133:920–54. [PubMed: 17967089]
12. Baanders AN, Heijmans M. The impact of chronic diseases: the partner’s perspective. Fam
Community Health 2007;30:305–17. [PubMed: 17873637]
CARPENTER et al. Page 8













13. Lewis MA, McBride CM, Pollak KI, Puleo E, Butterfield RM, Emmons KM. Understanding health
behavior change among couples: an interdependence and communal coping approach. Soc Sci Med
2006;62:1369–80. [PubMed: 16146666]
14. Das Chagas Medeiros MM, Ferraz MB, Quaresma MR. The effect of rheumatoid arthritis on the
quality of life of primary caregivers. J Rheumatol 2000;27:76–83. [PubMed: 10648021]
15. Hagedoorn M, Sanderman R, Bolks HN, Tuinstra J, Coyne JC. Distress in couples coping with cancer:
a meta-analysis and critical review of role and gender effects. Psychol Bull 2008;134:1–30. [PubMed:
18193993]
16. Yee JL, Schulz R. Gender differences in psychiatric morbidity among family caregivers: a review
and analysis. Gerontologist 2000;40:147–64. [PubMed: 10820918]
17. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, et al. Renal histology
in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int
2002;61:80–9. [PubMed: 11786087]
18. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ
1993;2:217–27. [PubMed: 8275167]
19. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual
framework and item selection. Med Care 1992;30:473–83. [PubMed: 1593914]
20. Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE. The SF-36 health survey as a generic
outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data
quality, scaling assumptions and score reliability. Med Care 1999;37 (Suppl 5):10–22.
21. Norton R. Measuring marital quality: a critical look at the dependent variable. J Marriage Fam
1983;45:141–51.
22. Ware, JE.; Kosinski, M. SF-36 physical & mental health summary scales: a manual for users of version
1. Lincoln (RI): QualityMetric; 2005.
23. Marks NF, Lambert JD, Choi H. Transitions to caregiving, gender, and psychological well-being: a
prospective US national study. J Marriage Fam 2002;64:657–67.
24. Piazza JR, Charles ST, Almeida DM. Living with chronic health conditions: age differences in
affective well-being. J Gerontol B Psychol Sci Soc Sci 2007;62:313–21.
25. Phillips DL, Sega BE. Sexual status and psychiatric symptoms. Am Sociol Rev 1969;34:58–72.
[PubMed: 5776179]
26. Nathanson CA. Illness and the feminine role: a theoretical review. Soc Sci Med 1975;9:57–62.
[PubMed: 1093257]
27. Cohen J. A power primer. Quant Meth Psych 1992;112:155–9.
28. Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
Best Pract Res Clin Rheumatol 2005;19:263–76. [PubMed: 15857795]
29. Eisenberger U, Fakhouri F, Vanille P, Beaufils H, Mahr A, Guillevin L, et al. ANCA-negative pauci-
immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 2005;20:1392–9.
[PubMed: 15855209]
30. Falk RJ, Jennette JC. ANCA are pathogenic: oh yes they are! J Am Soc Nephrol 2002;13:1977–9.
[PubMed: 12089397]
31. Heeringa P, Huugen D, Cohen P, Tervaert JW. Anti-neutrophil cytoplasmic autoantibodies and
leukocyte-endothelial interactions: a sticky connection? Trends Immunol 2005;26:561–4. [PubMed:
16139567]
32. Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil
cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632–8.
[PubMed: 16263885]
33. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment
resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med
2005;143:621–31. [PubMed: 16263884]
CARPENTER et al. Page 9














Norm-based health-related quality of life subscale scores for antineutrophil cytoplasmic
antibody–associated vasculitis (AAV) patients, their spouses, and the 1998 general US
population (ages 55– 64 years) (ref. 22). PF = physical functioning; RP = physical role
limitations; BP = bodily pain; GH = general health; VT = vitality/energy; SF = social
functioning; RE = emotional role limitations; MH = mental health/emotional well-being. * =
significant by t-test (α = 0.05).
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Table 1
Characteristics of patients and spouses
Characteristic (no.) Mean ± SD, (%) Skewness Kurtosis
Patient
 Age, years (n = 96) 57.0 ± 13.8 −0.40 −0.59
 Male (n = 97) (54.6)
 White (n = 97) (96.9)
 Education, years (n = 97) 14.7 ± 2.2 −0.62 −0.63
 Disease duration, years (n = 94) 4.4 ± 4.5 2.07 4.70
 Years married (n = 97) 30.1 ± 15.7 −0.22 −1.06
 Marital quality (n = 97) 8.3 ± 1.7 −1.33 1.66
 Comorbidity, % yes (n = 76)* (44.7)
 Disease activity (n = 80)† 2.0 ± 1.3 1.56 2.72
Spouse
 Age (n = 97) 56.6 ± 13.5 −0.50 −0.46
 White (n = 96) (92.7)
 Education, years (n = 96) 14.7 ± 2.1 −0.48 −0.97
 Marital quality (n = 96) 8.1 ± 1.8 −1.48 2.48
 Major medical condition, % yes (n = 76)* (30.3)
*
Measured on the followup questionnaire.
†
Measured on a 10-point scale where 1 = remission and 10 = most active disease.
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Table 2
Unadjusted and adjusted mean ± SD health-related quality of life subscale scores for antineutrophil cytoplasmic
antibody—associated vasculitis (AAV) patients and their spouses*
AAV patients Spouses
Subscale Male Female Male Female
Physical functioning 40.2 ± 12.1/42.5 44.2 ± 11.1/44.6 52.8 ± 5.4/51.7 49.7 ± 7.9/50.9
Physical role limitations 37.7 ± 11.1/46.7 38.6 ± 11.6/46.0 50.3 ± 10.0/48.8 48.4 ± 11.0/49.3
Emotional role limitation 42.4 ± 14.2/42.0 44.8 ± 12.4/44.2 52.5 ± 8.0/52.2 48.4 ± 10.5/47.7
Energy 44.6 ± 9.2/47.5 45.5 ± 9.0/48.5 54.2 ± 8.5/52.7 52.0 ± 10.1/52.8
Emotional well-being 48.7 ± 9.9/48.0 50.5 ± 10.0/52.1 54.2 ± 7.4/54.3 50.9 ± 8.5/50.4
Social functioning 43.5 ± 10.8/54.4 45.3 ± 9.2/53.9 52.8 ± 5.7/53.2 50.2 ± 9.0/50.0
Pain 47.2 ± 13.1/54.3 48.4 ± 11.8/55.7 54.0 ± 7.6/53.1 52.0 ± 10.1/53.0
General health 36.1 ± 10.4/38.7 37.5 ± 9.6/41.2 51.2 ± 7.8/49.7 50.8 ± 51.5/8.2
*
Values are the unadjusted mean ± SD/adjusted mean. Mean adjusted for age, race, education, disease activity, and disease duration. AAV patients
(male n = 51—52, female n = 43— 44); spouses (male = 44, female n = 52—53).
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Table 3
Correlations between patient and spouse health-related quality of life (HRQOL)
HRQOL dimension r P
Social functioning 0.39 < 0.001
Emotional role limitations 0.28 0.0075
Emotional well-being 0.25 0.01
Physical role limitations 0.25 0.01
Energy 0.25 0.01
Pain 0.23 0.02
General health 0.21 0.04
Physical functioning 0.15 0.15
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